K C Aalders1, A C M van Bommel2, T van Dalen3, G S Sonke4, P J van Diest5, L J Boersma6, M van der Heiden-van der Loo7. 1. Diakonessenhuis Utrecht, Utrecht, The Netherlands. Electronic address: kaalders@diakhuis.nl. 2. Leiden University Medical Center, Leiden, The Netherlands. 3. Diakonessenhuis Utrecht, Utrecht, The Netherlands. 4. Netherlands Cancer Institute, Amsterdam, The Netherlands. 5. University Medical Center Utrecht, Utrecht, The Netherlands. 6. University Hospital Maastricht - GROW (MAASTRO), Maastricht, The Netherlands. 7. Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.
Abstract
INTRODUCTION: Breast cancer treatment has evolved extensively over the past two decades with a shift towards less invasive local treatment and increased systemic treatment. The present study aimed to investigate the rates of local (LR) and regional (RR) recurrence and contralateral breast cancer (CBC), evaluating the influence of contributing factors. MATERIALS AND METHODS: We selected all female patients operated for unilateral primary breast cancer (anyTN, M0) between 2003 and 2008 from the Netherlands Cancer Registry. The 5-year risks of developing LR, RR and CBC were estimated using Kaplan-Meier statistics. The influence of various patient, tumour and treatment characteristics was subsequently assessed in multivariable analyses. RESULTS: A total of 52,626 patients were identified. The rates of LR, RR and CBC were 2.7%, 1.5% and 2.9%, respectively. The rates of LR and RR decreased significantly over time in the period 2003-2008, from 3.2% to 2.4% for LR and 1.8 to 1.3% for RR, both becoming lower than the risk of CBC of 2.8%. Multivariable analysis showed that age, tumour size, lymph node involvement, tumour histologic type, grade and hormone receptor status were significant prognosticators for LR and RR, but not for CBC. A trend towards a beneficial effect of breast conserving surgery on LR and RR was seen, while systemic therapy proved to have a protective effect on all three end-points. CONCLUSIONS: In breast cancer patients treated between 2003 and 2008 locoregional recurrence rates decreased and have ended up lower than the risk of developing CBC.
INTRODUCTION:Breast cancer treatment has evolved extensively over the past two decades with a shift towards less invasive local treatment and increased systemic treatment. The present study aimed to investigate the rates of local (LR) and regional (RR) recurrence and contralateral breast cancer (CBC), evaluating the influence of contributing factors. MATERIALS AND METHODS: We selected all female patients operated for unilateral primary breast cancer (anyTN, M0) between 2003 and 2008 from the Netherlands Cancer Registry. The 5-year risks of developing LR, RR and CBC were estimated using Kaplan-Meier statistics. The influence of various patient, tumour and treatment characteristics was subsequently assessed in multivariable analyses. RESULTS: A total of 52,626 patients were identified. The rates of LR, RR and CBC were 2.7%, 1.5% and 2.9%, respectively. The rates of LR and RR decreased significantly over time in the period 2003-2008, from 3.2% to 2.4% for LR and 1.8 to 1.3% for RR, both becoming lower than the risk of CBC of 2.8%. Multivariable analysis showed that age, tumour size, lymph node involvement, tumour histologic type, grade and hormone receptor status were significant prognosticators for LR and RR, but not for CBC. A trend towards a beneficial effect of breast conserving surgery on LR and RR was seen, while systemic therapy proved to have a protective effect on all three end-points. CONCLUSIONS: In breast cancerpatients treated between 2003 and 2008 locoregional recurrence rates decreased and have ended up lower than the risk of developing CBC.
Authors: Shoshana M Rosenberg; Mary L Greaney; Andrea F Patenaude; Ann H Partridge Journal: J Adolesc Young Adult Oncol Date: 2019-04-03 Impact factor: 2.223
Authors: Russell J Bramhall; Jason Lee; Mae Concepcion; David Westbroek; Sarah Huf; Kabir Mohammed; Paul Thiruchelvam; Gerald P Gui Journal: Gland Surg Date: 2017-12
Authors: Maureen L Groot Koerkamp; Jeanine E Vasmel; Nicola S Russell; Simona F Shaitelman; Carmel N Anandadas; Adam Currey; Danny Vesprini; Brian M Keller; Chiara De-Colle; Kathy Han; Lior Z Braunstein; Faisal Mahmood; Ebbe L Lorenzen; Marielle E P Philippens; Helena M Verkooijen; Jan J W Lagendijk; Antonetta C Houweling; H J G Desiree van den Bongard; Anna M Kirby Journal: Front Oncol Date: 2020-07-28 Impact factor: 6.244
Authors: Julia E C van Steenhoven; Anne Kuijer; Marissa C van Maaren; Marleen Roos; Sjoerd G Elias; Paul J van Diest; Sabine Siesling; Marjolein L Smidt; Liesbeth J Boersma; Thijs van Dalen Journal: Ann Surg Oncol Date: 2020-03-20 Impact factor: 5.344